Taxol inhibits melanoma metastases through apoptosis induction, angiogenesis inhibition, and restoration of E-cadherin and nm23 expression

Journal of Pharmacological Sciences

Volumn 93, Issue 2, 2003, Pages 197-203

  Wang, Fang ^a   Cao, Yu ^a   Zhao, WanZhou ^a   Liu, Hongyan ^a   Fu, Zhaodi ^a   Han, Rui ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Apoptosis; E cadherin; nm23; Taxol; Vascular endothelial growth factor

Indexed keywords

EOSIN; HEMATOXYLIN; PACLITAXEL; UVOMORULIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER MODEL; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; INHIBITION KINETICS; LUNG METASTASIS; MELANOMA; MOLECULAR MECHANICS; MORPHOLOGY; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; STAINING; TUMOR SUPPRESSOR GENE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CADHERINS; COLORING AGENTS; EOSINE YELLOWISH-(YS); FLUORESCENT DYES; HEMATOXYLIN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON; NEOVASCULARIZATION, PATHOLOGIC; NUCLEOSIDE-DIPHOSPHATE KINASE; PACLITAXEL; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0242468010     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.93.197     Document Type: Article

References (28)

1. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century. J Am Acad Dermatol. 1996;34:839-847.
2. Hall HI, Miller DR, Rogers JD, Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol. 1999;40:35-42.
3. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15-36.
4. Wingo PA, Ries LA, Giovino GA, et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 1999;91:675-690.
5. Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME. Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res. 1988;48:6550-6554.
6. Kalebic T, Williams JE, Talmadge JE, et al. A novel method for selection of invasive tumor cells: Derivation and characterization of highly metastatic K1735 melanoma cell lines based on in vitro and in vivo invasive capacity. Clin Exp Metastasis. 1988;6:301-318.
7. Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988;80:200-204.
8. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991;113:173-185.
9. Johnson JP. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev. 1999;18:345-357.
10. Denijn M, Ruiter DJ. The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects. Melanoma Res. 1993;3:5-14.
11. Johnson TM, Yahanda AM, Chang AE, Fader DJ, Sondak VK. Advances in melanoma therapy. J Am Acad Dermatol. 1998;38:721-741.
12. Straume O, Salvesen HB, Akslen LA. Angiogenesis is prognostically important in vertical growth phase melanoma. Int J Oncol. 1999;15:595-599.
13. Potgens AJ, Lubsen NH, Van Altena MC, Schoenmakers JGG, Ruiter DJ, De Waal RMW. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am J Pathol. 1995;146:197-209.
14. Claffey KP, Brown LF, Del Agulla LF, et al. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis and experimental metastasis. Cancer Res. 1996;56:172-181.
15. Oku U, Tjuvajev JG, Miyagawa T, et al. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake and proliferation of human melanoma intracerebral xenografts. Cancer Res. 1998;58:4185-4192.
16. Legha SS, Ring S, Papadopoulos, N, Raber M, Benjamin RS. A phase II trial of taxol in metastatic melanoma. Cancer. 1990;65:2478-2481.
17. Wiernik PH, Einzig AI. Taxol in malignant melanoma. J Natl Cancer Inst Monogr. 1993;15:185-187.
18. Ariazi EA, Satomi Y, Ellis MJ, et al. Activation of the transforming growth factor β signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol. Cancer Res. 1999;59:1917-1928.
19. O'Rourke KI, Baszler TV, Besser TE, et al. Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol. 2000;38:3254-3259.
20. Henrique D, Adam J, Myat A, Chitnis A, Lewis J, Ish-Horowicz D. Expression of a delta homologue in prospective neurons in the chick. Nature. 1995;375:787-790.
21. Photiou A, Shan P, Leong LK, Moss J, Retsas S. In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines. Eur J Cancer. 1997;33:463-470.
22. Imokawa G, Mishima Y. Importance of glycoproteins in the initiation of melanogenesis: An electron microscopic study of B-16 melanoma cells after release from inhibition of glycosylation. J Invest Dermatol. 1986;87:319-325.
23. Wood JM, Schallreuter KU. Studies on the reactions between human tyrosinase, superoxide anion, hydrogen peroxide and thiols. Biochim Biophys Acta. 1991;1074:378-385.
24. Kameyama K, Takemura T, Hamada Y, et al. Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein 1 (TRP1), DOPAchrome tautomerase (TRP2), and a melanogenic inhibitor. J Invest Dermatol. 1993;100:126-131.
25. Biumpaka C, Page M. Paclitaxel stimulates melanogenesis in B16-F1 melanoma cells. Anticancer Res. 1998;18:4101-4104.
26. Kelling J, Sullivan K, Wilson L, Jordan MA. Suppression of centromere dynamics by Taxol in living osteosarcoma cells. Cancer Res. 2003;63:2794-2801.
27. Inou K, Slaton JW, Davis DW, et al. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel. Clin Cancer Res. 2000;6:2635-2643.
28. Inoue K, Slaton JW, Perrotte P, et al. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma. Clin Cancer Res. 2000;6:4874-4884.